Daclatasvir Products | Cleanchem - Daclatasvir is a direct-acting antiviral used in the treatment of chronic hepatitis C virus (HCV) infections. It is usually combined with other antiviral medications like sofosbuvir. Daclatasvir works by inhibiting the NS5A protein, essential for viral replication.

Daclatasvir is a direct-acting antiviral used in the treatment of chronic hepatitis C virus (HCV) infections. It is usually combined with other antiviral medications like sofosbuvir. Daclatasvir works by inhibiting the NS5A protein, essential for viral replication.

Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Daclatasvir and its associated compounds...

Daclatasvir

Cat. No: CL-DCS-40

CAS No: 1009119-64-5

Mol. F: C40H50N8O6

Mol. Wt: 738.9

Inv. Status: In Stock

Daclatasvir Dihydrochloride

Cat. No: CL-DCS-20

CAS No: 1009119-65-6

Mol. F: C40H50N8O6 : 2(HCl)

Mol. Wt: 738.9 : 2(36.5)

Inv. Status: In Stock

Daclatasvir Impurity 1

Cat. No: CL-DCS-24

CAS No: 24860-53-5

Mol. F: C16H12Cl2O2

Mol. Wt: 307.2

Inv. Status: Custom Synthesis

Daclatasvir Impurity 11

Cat. No: CL-DCS-37

CAS No: 135-73-9

Mol. F: C14H11BrO

Mol. Wt: 275.1

Inv. Status: Custom Synthesis

Daclatasvir Impurity 2

Cat. No: CL-DCS-25

CAS No: 15761-39-4

Mol. F: C10H17NO4

Mol. Wt: 215.2

Inv. Status: In Stock

Daclatasvir Impurity 3

Cat. No: CL-DCS-26

CAS No: 1009119-82-7

Mol. F: C36H44N2O10

Mol. Wt: 664.8

Inv. Status: In Stock

Daclatasvir Impurity 4

Cat. No: CL-DCS-27

CAS No: 1007882-23-6

Mol. F: C36H44N6O4

Mol. Wt: 624.8

Inv. Status: In Stock

Daclatasvir Impurity 5 Tetrahydrochloride

Cat. No: CL-DCS-28

CAS No: 1009119-83-8

Mol. F: C26H28N6 : 4HCl

Mol. Wt: 424.6 : 4(36.5)

Inv. Status: In Stock

Daclatasvir Impurity 6

Cat. No: CL-DCS-29

CAS No: 74761-42-5

Mol. F: C7H13NO4

Mol. Wt: 175.2

Inv. Status: In Stock

Daclatasvir Impurity 7

Cat. No: CL-DCS-30

CAS No: 4072-67-7

Mol. F: C16H12Br2O2

Mol. Wt: 396.1

Inv. Status: In Stock

Daclatasvir Impurity 8 (4HCl)

Cat. No: CL-DCS-31

CAS No: NA

Mol. F: C26H28N6 : 4HCl

Mol. Wt: 424.6 : 4(36.5)

Inv. Status: Custom Synthesis

Daclatasvir Impurity 9

Cat. No: CL-DCS-32

CAS No: 1447744-93-5

Mol. F: C30H32N6O2

Mol. Wt: 508.6

Inv. Status: Custom Synthesis

Daclatasvir Impurity A

Cat. No: CL-DCS-17

CAS No: 1007884-60-7

Mol. F: C33H39N7O3

Mol. Wt: 581.7

Inv. Status: Custom Synthesis

Daclatasvir Impurity B

Cat. No: CL-DCS-18

CAS No: NA

Mol. F: C35H41N7O4

Mol. Wt: 623.8

Inv. Status: In Stock

Daclatasvir Impurity C

Cat. No: CL-DCS-19

CAS No: 1256385-55-3

Mol. F: C29H32N6O3

Mol. Wt: 512.6

Inv. Status: Custom Synthesis

Daclatasvir Impurity F

Cat. No: CL-DCS-34

CAS No: 2077207-88-4

Mol. F: C41H52N8O6

Mol. Wt: 752.9

Inv. Status: Custom Synthesis

Daclatasvir Impurity G

Cat. No: CL-DCS-33

CAS No: NA

Mol. F: C40H49N7O7

Mol. Wt: 739.9

Inv. Status: Custom Synthesis

Daclatasvir Impurity L

Cat. No: CL-DCS-35

CAS No: 787-69-9

Mol. F: C16H14O2

Mol. Wt: 238.3

Inv. Status: In Stock

Daclatasvir Impurity Q

Cat. No: CL-DCS-16

CAS No: NA

Mol. F: C7H14N2O3

Mol. Wt: 174.2

Inv. Status: Custom Synthesis

Daclatasvir RR Isomer

Cat. No: CL-DCS-05

CAS No: NA

Mol. F: C20H25BrN4O3

Mol. Wt: 449.3

Inv. Status: Custom Synthesis

Daclatasvir RRRR Isomer Enantiomer

Cat. No: CL-DCS-03

CAS No: 1417333-58-4

Mol. F: C40H50N8O6

Mol. Wt: 738.9

Inv. Status: Custom Synthesis

Daclatasvir RRRR Isomer Enantiomer (2HCl)

Cat. No: CL-DCS-36

CAS No: NA

Mol. F: C40H50N8O6 : 2HCl

Mol. Wt: 738.9 : 2(36.5)

Inv. Status: Custom Synthesis

Daclatasvir RRRS Isomer

Cat. No: CL-DCS-08

CAS No: NA

Mol. F: C40H50N8O6

Mol. Wt: 738.9

Inv. Status: Custom Synthesis

Daclatasvir RRSR Isomer

Cat. No: CL-DCS-07

CAS No: 1417333-65-3

Mol. F: C40H50N8O6

Mol. Wt: 738.9

Inv. Status: Custom Synthesis

Daclatasvir RRSS Isomer (2HCl)

Cat. No: CL-DCS-23

CAS No: NA

Mol. F: C40H50N8O6 : 2HCl

Mol. Wt: 738.9 : 2(36.5)

Inv. Status: Custom Synthesis

Daclatasvir RRSS Isomer Enantiomer

Cat. No: CL-DCS-09

CAS No: 1009107-27-0

Mol. F: C40H50N8O6 : 2HCl

Mol. Wt: 738.9:36.5

Inv. Status: Custom Synthesis

Daclatasvir RS Isomer

Cat. No: CL-DCS-10

CAS No: NA

Mol. F: C20H25BrN4O3

Mol. Wt: 449.3

Inv. Status: Custom Synthesis

Daclatasvir RSRR Isomer

Cat. No: CL-DCS-22

CAS No: 1417333-60-8

Mol. F: C40H50N8O6

Mol. Wt: 738.9

Inv. Status: Custom Synthesis

Daclatasvir RSSR Isomer

Cat. No: CL-DCS-01

CAS No: 1009107-27-0

Mol. F: C40H50N8O6

Mol. Wt: 738.9

Inv. Status: Custom Synthesis

Daclatasvir RSSS Isomer

Cat. No: CL-DCS-06

CAS No: 1417333-83-5

Mol. F: C40H50N8O6

Mol. Wt: 738.9

Inv. Status: Custom Synthesis

Daclatasvir SR Isomer

Cat. No: CL-DCS-11

CAS No: NA

Mol. F: C20H25BrN4O3

Mol. Wt: 449.3

Inv. Status: Custom Synthesis

Daclatasvir SRRR Isomer

Cat. No: CL-DCS-12

CAS No: NA

Mol. F: C40H50N8O6

Mol. Wt: 738.9

Inv. Status: Custom Synthesis

Daclatasvir SRRS Isomer

Cat. No: CL-DCS-02

CAS No: 1009117-26-3

Mol. F: C40H50N8O6

Mol. Wt: 738.9

Inv. Status: Custom Synthesis

Daclatasvir SS Isomer

Cat. No: CL-DCS-04

CAS No: 1228552-27-9

Mol. F: C20H25BrN4O3

Mol. Wt: 449.3

Inv. Status: Custom Synthesis

Daclatasvir SSRR- Isomer

Cat. No: CL-DCS-15

CAS No: 1009117-94-5

Mol. F: C40H50N8O6

Mol. Wt: 738.9

Inv. Status: Custom Synthesis

Daclatasvir SSRS Isomer

Cat. No: CL-DCS-13

CAS No: 1009117-94-5

Mol. F: C40H50N8O6

Mol. Wt: 738.9

Inv. Status: Custom Synthesis

Daclatasvir SSSR Isomer

Cat. No: CL-DCS-14

CAS No: NA

Mol. F: C40H50N8O6

Mol. Wt: 738.9

Inv. Status: Custom Synthesis

Daclatasvir-d6

Cat. No: CL-DCS-38

CAS No: 1801709-41-0

Mol. F: C40H44D6N8O6

Mol. Wt: 744.9

Inv. Status: Custom Synthesis